Xtant Medical Holdings (XTNT) Gross Profit (2016 - 2025)
Xtant Medical Holdings has reported Gross Profit over the past 16 years, most recently at $17.8 million for Q4 2025.
- Quarterly Gross Profit rose 10.8% to $17.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $84.3 million through Dec 2025, up 23.54% year-over-year, with the annual reading at $84.3 million for FY2025, 23.54% up from the prior year.
- Gross Profit was $17.8 million for Q4 2025 at Xtant Medical Holdings, down from $22.0 million in the prior quarter.
- Over five years, Gross Profit peaked at $24.3 million in Q2 2025 and troughed at $7.2 million in Q3 2021.
- The 5-year median for Gross Profit is $13.9 million (2023), against an average of $13.6 million.
- Year-over-year, Gross Profit dropped 22.24% in 2021 and then soared 106.32% in 2023.
- A 5-year view of Gross Profit shows it stood at $7.7 million in 2021, then increased by 7.94% to $8.3 million in 2022, then soared by 106.32% to $17.1 million in 2023, then dropped by 6.49% to $16.0 million in 2024, then rose by 10.8% to $17.8 million in 2025.
- Per Business Quant, the three most recent readings for XTNT's Gross Profit are $17.8 million (Q4 2025), $22.0 million (Q3 2025), and $24.3 million (Q2 2025).